Hybrid bioartificial liver in hepatic failure: preliminary clinical report.
A hybrid bioartificial liver has been developed on the principle of hemodialysis against a suspension of functioning hepatocytes. The new chimeric device of synthetics and living parts was used successfully to treat a patient in hepatic failure due to an inoperable bile duct carcinoma that involved the bifurcation of the common duct.
D000818:Animals; D001187:Artificial Organs; D001663:Bilirubin / Q000378:metabolism; D001672:Biocompatible Materials; D005112:Extracorporeal Circulation; D006801:Humans; D008099:Liver / Q000166:cytology; D008107:Liver Diseases / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011817:Rabbits
D001672:Biocompatible Materials; D001663:Bilirubin